Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 141

Similar articles for PubMed (Select 21750735)

1.

Incidence, clinical features and impact on anti-tuberculosis treatment of anti-tuberculosis drug induced liver injury (ATLI) in China.

Shang P, Xia Y, Liu F, Wang X, Yuan Y, Hu D, Tu D, Chen Y, Deng P, Cheng S, Zhou L, Ma Y, Zhu L, Gao W, Wang H, Chen D, Yang L, He P, Wu S, Tang S, Lv X, Shu Z, Zhang Y, Yang Z, Chen Y, Li N, Sun F, Li X, He Y, Garner P, Zhan S.

PLoS One. 2011;6(7):e21836. doi: 10.1371/journal.pone.0021836. Epub 2011 Jul 5.

2.

An open-label, randomized and multi-center clinical trial to evaluate the efficacy of Silibinin in preventing drug-induced liver injury.

Gu J, Tang SJ, Tan SY, Wu Q, Zhang X, Liu CX, Gao XS, Yuan BD, Han LJ, Gao AP, Wu MY, Huang LH, Ma J, Xiao HP.

Int J Clin Exp Med. 2015 Mar 15;8(3):4320-7. eCollection 2015.

3.

Drug-induced hepatotoxicity and tuberculosis in a hospital from the Argentinian northeast: cross-sectional study.

Golemba AS, Ferreyra FG, Martearena RE, Achinelli FR, Rovai GB.

Medwave. 2015 May 4;15(4):e6135. doi: 10.5867/medwave.2015.04.6135. Spanish, English.

PMID:
26035138
4.

Tuberculosis control strategies to reach the 2035 global targets in China: the role of changing demographics and reactivation disease.

Huynh GH, Klein DJ, Chin DP, Wagner BG, Eckhoff PA, Liu R, Wang L.

BMC Med. 2015 Apr 21;13:88. doi: 10.1186/s12916-015-0341-4.

5.

Role of bicyclol in preventing drug-induced liver injury in tuberculosis patients with liver disease.

Chu NH, Li L, Zhang X, Gu J, Du YD, Cai C, Xiao HP.

Int J Tuberc Lung Dis. 2015 Apr;19(4):475-80. doi: 10.5588/ijtld.14.0579.

PMID:
25860005
6.

Common risk factors for the development of anti tuberculosis treatment induced hepatotoxicity.

Abbasi MA, Ahmed N, Suleman A, Zaman H, Tariq S, Anwar SA, Khan N.

J Ayub Med Coll Abbottabad. 2014 Jul-Sep;26(3):384-8.

PMID:
25671954
7.

Drug-induced hepatotoxicity of anti-tuberculosis drugs and their serum levels.

Jeong I, Park JS, Cho YJ, Yoon HI, Song J, Lee CT, Lee JH.

J Korean Med Sci. 2015 Feb;30(2):167-72. doi: 10.3346/jkms.2015.30.2.167. Epub 2015 Jan 21.

8.

Clinical features and treatment of drug fever caused by anti-tuberculosis drugs.

Fang Y, Xiao H, Tang S, Liang L, Sha W, Fang Y.

Clin Respir J. 2014 Nov 17. doi: 10.1111/crj.12242. [Epub ahead of print]

PMID:
25401489
9.

Association of the CYP2B6 gene with anti-tuberculosis drug-induced hepatotoxicity in a Brazilian Amazon population.

Fernandes DC, Santos NP, Moraes MR, Braga AC, Silva CA, Ribeiro-dos-Santos A, Santos S.

Int J Infect Dis. 2015 Apr;33:28-31. doi: 10.1016/j.ijid.2014.04.011. Epub 2014 Sep 28.

10.
11.

The association between HLA-DQB1 polymorphism and antituberculosis drug-induced liver injury: a Case-Control Study.

Chen R, Zhang Y, Tang S, Lv X, Wu S, Sun F, Xia Y, Zhan SY.

J Clin Pharm Ther. 2015 Feb;40(1):110-5. doi: 10.1111/jcpt.12211. Epub 2014 Sep 24.

PMID:
25250564
12.

Preventive use of hepatoprotectors yields limited efficacy on the liver toxicity of anti-tuberculosis agents in a large cohort of Chinese patients.

Wu S, Xia Y, Lv X, Tang S, Yang Z, Zhang Y, Wang X, Hu D, Liu F, Yuan Y, Tu D, Sun F, Zhou L, Zhan S.

J Gastroenterol Hepatol. 2015 Mar;30(3):540-5. doi: 10.1111/jgh.12717.

PMID:
25160904
13.

Tuberculosis in SLE patients: rare diagnosis, risky treatment.

Ruangnapa K, Dissaneewate P, Vachvanichsanong P.

Clin Exp Med. 2014 Aug 7. [Epub ahead of print]

PMID:
25099176
14.

Efficacy of Jian'ganle () versus Hugan Pian (), glucuronolactone and reduced glutathione in prevention of antituberculosis drug-induced liver injury.

Zhang Q, Zhong FY, Wu M, Zhang XP.

J Huazhong Univ Sci Technolog Med Sci. 2014 Jun;34(3):450-5. doi: 10.1007/s11596-014-1299-8. Epub 2014 Jun 18.

PMID:
24939315
15.

Future of pharmacogenetics-based therapy for tuberculosis.

Matsumoto T, Ohno M, Azuma J.

Pharmacogenomics. 2014 Apr;15(5):601-7. doi: 10.2217/pgs.14.38. Review.

PMID:
24798717
16.

Impact of chronic renal failure on anti-tuberculosis treatment outcomes.

Baghaei P, Marjani M, Tabarsi P, Moniri A, Rashidfarrokhi F, Ahmadi F, Nassiri AA, Masjedi MR, Velayati AA, Cattamanchi A.

Int J Tuberc Lung Dis. 2014 Mar;18(3):352-6. doi: 10.5588/ijtld.13.0726.

PMID:
24670575
18.

Clinical analysis of 275 cases of acute drug-induced liver disease.

Li L, Jiang W, Wang J.

Front Med China. 2007 Feb;1(1):58-61. doi: 10.1007/s11684-007-0012-8. Epub 2007 Feb 1.

PMID:
24557619
19.

Association of genetic variants with anti-tuberculosis drug induced hepatotoxicity: a high resolution melting analysis.

Singh M, Gupta VH, Amarapurkar DN, Joshi JM, Baijal R, Ramegowda PH, Amarapurkar AD, Wangikar PP.

Infect Genet Evol. 2014 Apr;23:42-8. doi: 10.1016/j.meegid.2014.01.027. Epub 2014 Jan 31.

PMID:
24491431
20.

The incidence of liver injury in Uyghur patients treated for TB in Xinjiang Uyghur autonomous region, China, and its association with hepatic enzyme polymorphisms nat2, cyp2e1, gstm1 and gstt1.

Xiang Y, Ma L, Wu W, Liu W, Li Y, Zhu X, Wang Q, Ma J, Cao M, Wang Q, Yao X, Yang L, Wubuli A, Merle C, Milligan P, Mao Y, Gu J, Xin X.

PLoS One. 2014 Jan 23;9(1):e85905. doi: 10.1371/journal.pone.0085905. eCollection 2014.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk